This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.
- kidney transplantation
- Mammalian target of rapamycin (mTOR) inhibitors
Wong, G., Chapman, J. R., & Craig, J. C. (2012). mTOR Inhibitors: a myth, a cure for cancer or something in between? American Journal of Transplantation, 12(5), 1075-1076. https://doi.org/10.1111/j.1600-6143.2012.04007.x